WallStreetZenWallStreetZen

NASDAQ: SHC
Sotera Health Co Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SHC

Based on 6 analysts offering 12 month price targets for Sotera Health Co

Min Forecast
$18.00-2.76%
Avg Forecast
$22.17+19.76%
Max Forecast
$25.00+35.06%

Should I buy or sell SHC stock?

Based on 6 analysts offering ratings for Sotera Health Co.

Strong Buy
Strong Buy
5 analysts 83.33%
Buy
0 analysts 0%
Hold
1 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Buy" agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their SHC stock forecasts and price targets.

SHC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-07
lockedlocked$00.00+00.00%2026-08-07Find Out Why
lockedlocked$00.00+00.00%2026-08-07
lockedlocked$00.00+00.00%2026-08-07
lockedlocked$00.00+00.00%2026-06-05
Citigroup
Top 16%
85
Strong BuyMaintains$23.00+24.26%2026-02-24Find out why

1 of 1

Forecast return on equity

Is SHC forecast to generate an efficient return?

Company
54.56%
Industry
383.09%
Market
168.68%
SHC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SHC forecast to generate an efficient return on assets?

Company
10.98%
Industry
14.97%
SHC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SHC earnings per share forecast

What is SHC's earnings per share in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
$0.98+71.25%
Avg 2 year Forecast
$1.07+87.72%
Avg 3 year Forecast
$1.18+106.84%
SHC's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

SHC revenue forecast

What is SHC's revenue in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
$1.3B+3.03%
Avg 2 year Forecast
$1.3B+9.11%
Avg 3 year Forecast
$1.4B+15.77%
SHC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SHC earnings growth forecast

How is SHC forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
27.29%
Industry
18.46%
Market
30.55%
SHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
SHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
SHC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

SHC revenue growth forecast

How is SHC forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
4.96%
Industry
7.34%
Market
13.39%
SHC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SHC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SHC vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
SHC$18.51$22.17+19.76%Strong Buy
RDNT$73.83$79.50+7.68%Strong Buy
BLLN$87.99$118.75+34.96%Strong Buy
TWST$116.10$101.63-12.47%Strong Buy
GRAL$70.89$68.38-3.55%Buy
View Top Diagnostic & Research Stocks

Sotera Health Co Stock Forecast FAQ

Is Sotera Health Co Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: SHC) stock is to Strong Buy SHC stock.

Out of 6 analysts, 5 (83.33%) are recommending SHC as a Strong Buy, 0 (0%) are recommending SHC as a Buy, 1 (16.67%) are recommending SHC as a Hold, 0 (0%) are recommending SHC as a Sell, and 0 (0%) are recommending SHC as a Strong Sell.

If you're new to stock investing, here's how to buy Sotera Health Co stock.

What is SHC's earnings growth forecast for 2026-2028?

(NASDAQ: SHC) Sotera Health Co's forecast annual earnings growth rate of 27.29% is forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 18.46%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.55%.

Sotera Health Co's earnings in 2026 is $163,479,000.On average, 12 Wall Street analysts forecast SHC's earnings for 2026 to be $278,554,337, with the lowest SHC earnings forecast at $264,570,972, and the highest SHC earnings forecast at $296,647,099. On average, 12 Wall Street analysts forecast SHC's earnings for 2027 to be $305,351,031, with the lowest SHC earnings forecast at $290,853,991, and the highest SHC earnings forecast at $323,615,018.

In 2028, SHC is forecast to generate $336,456,883 in earnings, with the lowest earnings forecast at $318,820,721 and the highest earnings forecast at $359,572,242.

What is SHC's revenue growth forecast for 2026-2028?

(NASDAQ: SHC) Sotera Health Co's forecast annual revenue growth rate of 4.96% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.39%.

Sotera Health Co's revenue in 2026 is $1,216,173,000.On average, 12 Wall Street analysts forecast SHC's revenue for 2026 to be $357,574,618,135, with the lowest SHC revenue forecast at $345,588,876,745, and the highest SHC revenue forecast at $372,414,107,475. On average, 12 Wall Street analysts forecast SHC's revenue for 2027 to be $378,692,352,965, with the lowest SHC revenue forecast at $365,565,112,395, and the highest SHC revenue forecast at $396,385,590,255.

In 2028, SHC is forecast to generate $401,807,711,360 in revenue, with the lowest revenue forecast at $386,397,472,430 and the highest revenue forecast at $420,642,447,830.

What is SHC's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: SHC) forecast ROA is 10.98%, which is lower than the forecast US Diagnostics & Research industry average of 14.97%.

What is SHC's Price Target?

According to 6 Wall Street analysts that have issued a 1 year SHC price target, the average SHC price target is $22.17, with the highest SHC stock price forecast at $25.00 and the lowest SHC stock price forecast at $18.00.

On average, Wall Street analysts predict that Sotera Health Co's share price could reach $22.17 by Aug 7, 2027. The average Sotera Health Co stock price prediction forecasts a potential upside of 19.76% from the current SHC share price of $18.51.

What is SHC's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: SHC) Sotera Health Co's current Earnings Per Share (EPS) is $0.57. On average, analysts forecast that SHC's EPS will be $0.98 for 2026, with the lowest EPS forecast at $0.93, and the highest EPS forecast at $1.04. On average, analysts forecast that SHC's EPS will be $1.07 for 2027, with the lowest EPS forecast at $1.02, and the highest EPS forecast at $1.13. In 2028, SHC's EPS is forecast to hit $1.18 (min: $1.12, max: $1.26).

What is SHC's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: SHC) forecast ROE is 54.56%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.